Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Rheumatoid Arthritis

  Free Subscription


Articles published in Ann Rheum Dis

Retrieve available abstracts of 347 articles:
HTML format



Single Articles


    June 2020

  1. Correction: Is treat-to-target really working in rheumatoid arthritis? A longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).
    Ann Rheum Dis. 2020;79:e77.
    PubMed    


    May 2020
  2. EMERY P, Burmester GR, Naredo E, Sinigaglia L, et al
    Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study.
    Ann Rheum Dis. 2020 May 13. pii: annrheumdis-2020-217246.
    PubMed     Abstract available


  3. ZHAO SS, Lyu H, Solomon DH, Yoshida K, et al
    Improving rheumatoid arthritis comparative effectiveness research through causal inference principles: systematic review using a target trial emulation framework.
    Ann Rheum Dis. 2020 May 7. pii: annrheumdis-2020-217200.
    PubMed     Abstract available


  4. SHAFRAN IH, Alasti F, Smolen JS, Aletaha D, et al
    Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab.
    Ann Rheum Dis. 2020 May 5. pii: annrheumdis-2019-215987.
    PubMed     Abstract available


  5. GUO J, Zhang T, Li X, Cao H, et al
    Response to: 'Questions on 'Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population' by Guo et al' by Regueiro and Gonzalez.
    Ann Rheum Dis. 2020 May 5. pii: annrheumdis-2020-217064.
    PubMed    


    April 2020
  6. ZHANG Y, Wang J, Zhao L, Xiao J, et al
    Online management of rheumatoid arthritis during COVID-19 pandemic.
    Ann Rheum Dis. 2020 Apr 27. pii: annrheumdis-2020-217548.
    PubMed    


  7. ATTIPOE L, Chaabo K, Wajed J, Hassan FU, et al
    Imaging neoangiogenesis in rheumatoid arthritis (INIRA): whole-body synovial uptake of a (99m)Tc-labelled RGD peptide is highly correlated with power Doppler ultrasound.
    Ann Rheum Dis. 2020 Apr 23. pii: annrheumdis-2020-217228.
    PubMed    



  8. Correction: Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population.
    Ann Rheum Dis. 2020 Apr 20. pii: annrheumdis-2018-214725.
    PubMed    


  9. BUGATTI S, De Stefano L, Favalli EG, Caporali R, et al
    Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis.
    Ann Rheum Dis. 2020 Apr 20. pii: annrheumdis-2020-217488.
    PubMed    


  10. HSIEH PH, Wu O, Geue C, McIntosh E, et al
    Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era.
    Ann Rheum Dis. 2020 Apr 3. pii: annrheumdis-2019-216243.
    PubMed     Abstract available


  11. PAZMINO S, Boonen A, Stouten V, De Cock D, et al
    Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial.
    Ann Rheum Dis. 2020 Apr 2. pii: annrheumdis-2019-216874.
    PubMed     Abstract available


  12. ALUNNO A, Bistoni O, Bonifacio AF, Gerli R, et al
    Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a 'mix-and-match' approach?
    Ann Rheum Dis. 2020 Apr 2. pii: annrheumdis-2020-217410.
    PubMed    


  13. AUNGIER S, Cartwright AJ, Schwenzer A, Marshall J, et al
    Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al.
    Ann Rheum Dis. 2020;79:e43.
    PubMed    


  14. LAUPER K, Courvoisier DS, Gabay C
    Response to: 'When binary and continuous responses disagree' by Dr Ouyang.
    Ann Rheum Dis. 2020;79:e39.
    PubMed    


  15. OUYANG F
    When binary and continuous responses disagree.
    Ann Rheum Dis. 2020;79:e38.
    PubMed    


  16. SUN JL, Zhang HZ, Liu SY, Lian CF, et al
    Elevated EPSTI1 promote B cell hyperactivation through NF-kappaB signalling in patients with primary Sjogren's syndrome.
    Ann Rheum Dis. 2020;79:518-524.
    PubMed     Abstract available


  17. GODMANN L, Bollmann M, Korb-Pap A, Konig U, et al
    Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling.
    Ann Rheum Dis. 2020;79:481-489.
    PubMed     Abstract available


  18. KISSEL T, Reijm S, Slot LM, Cavallari M, et al
    Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications.
    Ann Rheum Dis. 2020;79:472-480.
    PubMed     Abstract available


  19. EMERY P, Horton S, Dumitru RB, Naraghi K, et al
    Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial.
    Ann Rheum Dis. 2020;79:464-471.
    PubMed     Abstract available


    March 2020
  20. KISHIKAWA T, Maeda Y, Nii T, Okada Y, et al
    Response to: 'Can sexual dimorphism in rheumatoid arthritis be attributed to the different abundance of Gardnerella?' by Liu et al.
    Ann Rheum Dis. 2020 Mar 25. pii: annrheumdis-2020-217264.
    PubMed    


  21. GEORGE MD, Baker JF, Winthrop KL, Goldstein SD, et al
    Immunosuppression and the risk of readmission and mortality in patients with rheumatoid arthritis undergoing hip fracture, abdominopelvic and cardiac surgery.
    Ann Rheum Dis. 2020 Mar 24. pii: annrheumdis-2019-216802.
    PubMed     Abstract available


  22. WINTHROP KL, Wouters A, Choy EH, Chen C, et al
    Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib.
    Ann Rheum Dis. 2020 Mar 11. pii: annrheumdis-2019-216566.
    PubMed    


  23. WADSTROM H, Pettersson A, Smedby KE, Askling J, et al
    Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors.
    Ann Rheum Dis. 2020 Mar 11. pii: annrheumdis-2019-216756.
    PubMed     Abstract available


  24. CASTELLANOS-MOREIRA R, Rodriguez-Garcia SC, Gomara MJ, Ruiz-Esquide V, et al
    Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease.
    Ann Rheum Dis. 2020 Mar 10. pii: annrheumdis-2019-216709.
    PubMed     Abstract available


  25. LIU D, Zhang F, Cao H, Wang X, et al
    Can sexual dimorphism in rheumatoid arthritis be attributed to the different abundance of Gardnerella?
    Ann Rheum Dis. 2020 Mar 10. pii: annrheumdis-2020-217214.
    PubMed    


  26. PISETSKY DS, Spencer DM, Lipsky PE, Rovin BH, et al
    Response to: 'Can solid-phase assays replace immunofluorescence for ANA screening?' by Bizzaro.
    Ann Rheum Dis. 2020;79:e33.
    PubMed    


  27. BERGSTRA SA, Allaart CF, Landewe RBM
    Response to: 'Catching the falling star: points to consider when using propensity scores' by Ouyang et al.
    Ann Rheum Dis. 2020;79:e27.
    PubMed    


  28. OUYANG F
    Catching the falling star: points to consider when using propensity scores.
    Ann Rheum Dis. 2020;79:e26.
    PubMed    


  29. MANKIA K, D'Agostino MA, Emery P
    Response to: 'Ultrasound findings in palindromic rheumatism' by Sanmarti et al.
    Ann Rheum Dis. 2020;79:e31.
    PubMed    


  30. SANMARTI R, Ramirez J, Castellanos-Moreira R, Cabrera-Villalba SR, et al
    Ultrasound findings in palindromic rheumatism.
    Ann Rheum Dis. 2020;79:e30.
    PubMed    


  31. VAN DER HELM-VAN MIL A, Landewe RBM
    The earlier, the better or the worse? Towards accurate management of patients with arthralgia at risk for RA.
    Ann Rheum Dis. 2020;79:312-315.
    PubMed     Abstract available


  32. ATTUR M, Zhou H, Samuels J, Krasnokutsky S, et al
    Interleukin 1 receptor antagonist (IL1RN) gene variants predict radiographic severity of knee osteoarthritis and risk of incident disease.
    Ann Rheum Dis. 2020;79:400-407.
    PubMed     Abstract available


    February 2020
  33. RAMIRO S, Landewe RB, van der Heijde D, Sepriano A, et al
    Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).
    Ann Rheum Dis. 2020 Feb 24. pii: annrheumdis-2019-216819.
    PubMed     Abstract available


  34. SOUTO-CARNEIRO M, Toth L, Behnisch R, Urbach K, et al
    Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis.
    Ann Rheum Dis. 2020 Feb 20. pii: annrheumdis-2019-216374.
    PubMed     Abstract available


  35. MYASOEDOVA E, Davis J, Matteson EL, Crowson CS, et al
    Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985-2014.
    Ann Rheum Dis. 2020 Feb 17. pii: annrheumdis-2019-216694.
    PubMed     Abstract available


  36. SEPRIANO A, Kerschbaumer A, Smolen JS, van der Heijde D, et al
    Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Ann Rheum Dis. 2020 Feb 7. pii: annrheumdis-2019-216653.
    PubMed     Abstract available


  37. KERSCHBAUMER A, Sepriano A, Smolen JS, van der Heijde D, et al
    Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.
    Ann Rheum Dis. 2020 Feb 7. pii: annrheumdis-2019-216656.
    PubMed     Abstract available


  38. SAFY-KHAN M, Jacobs JWG, de Hair MJH, Welsing PMJ, et al
    Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy.
    Ann Rheum Dis. 2020 Feb 7. pii: annrheumdis-2019-216537.
    PubMed     Abstract available


  39. STUDENIC P, Felson D, de Wit M, Alasti F, et al
    Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?
    Ann Rheum Dis. 2020 Feb 5. pii: annrheumdis-2019-216529.
    PubMed     Abstract available


  40. REGUEIRO C, Gonzalez A
    Questions on 'Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population' by Guo et al.
    Ann Rheum Dis. 2020 Feb 5. pii: annrheumdis-2020-217031.
    PubMed    


  41. MOFORS J, Bjork A, Smedby KE, Kvarnstrom M, et al
    Increased risk of multiple myeloma in primary Sjogren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies.
    Ann Rheum Dis. 2020;79:307-308.
    PubMed    


  42. KANEKO Y, Kameda H, Ikeda K, Ishii T, et al
    Response to: 'Some concerns from Turkey' by Bilgin et al.
    Ann Rheum Dis. 2020;79:e16.
    PubMed    


  43. BILGIN E, Ozarli I, Kilic L, Bolek EC, et al
    Some concerns from Turkey.
    Ann Rheum Dis. 2020;79:e15.
    PubMed    


    January 2020
  44. TAKANASHI S, Kaneko Y, Takeuchi T
    CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice.
    Ann Rheum Dis. 2020 Jan 29. pii: annrheumdis-2019-216607.
    PubMed    


  45. ROTHSCHILD BM
    The cost of arthralgia 'pretreatment' to prevent rheumatoid arthritis.
    Ann Rheum Dis. 2020 Jan 24. pii: annrheumdis-2020-216981.
    PubMed    


  46. SMOLEN JS, Landewe RBM, Bijlsma JWJ, Burmester GR, et al
    EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
    Ann Rheum Dis. 2020 Jan 22. pii: annrheumdis-2019-216655.
    PubMed     Abstract available


  47. ROSENZWAJG M, Lorenzon R, Klatzmann D
    Response to: 'Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors' by Meyer et al.
    Ann Rheum Dis. 2020 Jan 21. pii: annrheumdis-2019-216598.
    PubMed    


  48. LEE YH
    Causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study.
    Ann Rheum Dis. 2020 Jan 10. pii: annrheumdis-2019-216747.
    PubMed    


  49. INAMO J
    Response to: 'Causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study' by Lee.
    Ann Rheum Dis. 2020 Jan 10. pii: annrheumdis-2019-216767.
    PubMed    


  50. VAN DEN HOOGEN LL, van der Heijden EHM, Hillen MR, Mertens JS, et al
    Galectin-9 reflects the interferon signature and correlates with disease activity in systemic autoimmune diseases. Response to: 'Biomarkers: to be or not to be' by Yavuz and Ronnblom.
    Ann Rheum Dis. 2020;79:e9.
    PubMed    


  51. RAMOS-CASALS M, Brito-Zeron P, Bombardieri S, Bootsma H, et al
    EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies.
    Ann Rheum Dis. 2020;79:3-18.
    PubMed     Abstract available


  52. WINTHROP KL, Weinblatt ME, Bathon J, Burmester GR, et al
    Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.
    Ann Rheum Dis. 2020;79:88-93.
    PubMed     Abstract available


  53. LEE AY, Chataway T, Gordon TP, Wang JJ, et al
    Molecular typing of cryoglobulins by mass spectrometry.
    Ann Rheum Dis. 2020;79:163-164.
    PubMed    


  54. TAKESHITA M, Suzuki K, Kaneda Y, Yamane H, et al
    Antigen-driven selection of antibodies against SSA, SSB and the centromere 'complex', including a novel antigen, MIS12 complex, in human salivary glands.
    Ann Rheum Dis. 2020;79:150-158.
    PubMed     Abstract available


  55. LI Z, Liu HL, Chen J, Zeng T, et al
    Both HLA class I and II regions identified as genome-wide significant susceptibility loci for adult-onset Still's disease in Chinese individuals.
    Ann Rheum Dis. 2020;79:161-163.
    PubMed    


  56. BECH B, Primdahl J, van Tubergen A, Voshaar M, et al
    2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis.
    Ann Rheum Dis. 2020;79:61-68.
    PubMed     Abstract available


  57. PACHECO Y, Monsalve DM, Acosta-Ampudia Y, Rojas C, et al
    Antinuclear autoantibodies: discordance among four different assays.
    Ann Rheum Dis. 2020;79:e6.
    PubMed    


  58. KILTZ U, Kiefer D, Braun J, Schiffrin EJ, et al
    Prolonged treatment with Tadekinig alfa in adult-onset Still's disease.
    Ann Rheum Dis. 2020;79:e10.
    PubMed    


    December 2019
  59. MONNET E, Choy EH, McInnes I, Kobakhidze T, et al
    Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study.
    Ann Rheum Dis. 2019 Dec 31. pii: annrheumdis-2019-216487.
    PubMed     Abstract available


  60. ROGIER C, Hayer S, van der Helm-van Mil A
    Not only synovitis but also tenosynovitis needs to be considered: why it is time to update textbook images of rheumatoid arthritis.
    Ann Rheum Dis. 2019 Dec 19. pii: annrheumdis-2019-216350.
    PubMed    


  61. WANG Y, Chen S, Chen J, Xie X, et al
    Germline genetic patterns underlying across familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjogren's syndrome highlight T cell-initiated autoimmunity.
    Ann Rheum Dis. 2019 Dec 17. pii: annrheumdis-2019-215533.
    PubMed     Abstract available


  62. TANAKA Y, Oba K, Takeuchi T
    Response to: 'Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al' by Berkhout et al.
    Ann Rheum Dis. 2019 Dec 9. pii: annrheumdis-2019-216593.
    PubMed    



  63. Correction: Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell. A meta-analysis and functional study.
    Ann Rheum Dis. 2019;78:e144.
    PubMed    


    November 2019
  64. ALPIZAR RODRIGUEZ D, Lesker TR, Gilbert B, Strowig T, et al
    Intestinal dysbiosis in RA development: difficulty of establishing causality. Response to: 'Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study' by Inamo.
    Ann Rheum Dis. 2019 Nov 28. pii: annrheumdis-2019-216637.
    PubMed    


  65. KIRKHAM J, Christensen R, Boers M
    Use of composite outcomes facilitate core outcome set uptake in rheumatoid arthritis trials.
    Ann Rheum Dis. 2019 Nov 19. pii: annrheumdis-2019-216256.
    PubMed    


  66. MEYER A, Wittekind PS, Kotschenreuther K, Schiller J, et al
    Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors.
    Ann Rheum Dis. 2019 Nov 19. pii: annrheumdis-2019-216576.
    PubMed    


  67. BERKHOUT LC, l'Ami MJ, Wolbink GJ, Rispens T, et al
    Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al.
    Ann Rheum Dis. 2019 Nov 19. pii: annrheumdis-2019-216557.
    PubMed    


  68. INAMO J
    Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study.
    Ann Rheum Dis. 2019 Nov 19. pii: annrheumdis-2019-216565.
    PubMed    


  69. KISHIKAWA T, Maeda Y, Nii T, Motooka D, et al
    Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population.
    Ann Rheum Dis. 2019 Nov 7. pii: annrheumdis-2019-215743.
    PubMed     Abstract available


    October 2019
  70. MATHIJSSEN EGE, Vriezekolk JE, Popa CD, van den Bemt BJF, et al
    Shared decision making in routine clinical care of patients with rheumatoid arthritis: an assessment of audio-recorded consultations.
    Ann Rheum Dis. 2019 Oct 29. pii: annrheumdis-2019-216137.
    PubMed     Abstract available


  71. TANAKA Y, Oba K, Koike T, Miyasaka N, et al
    Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial.
    Ann Rheum Dis. 2019 Oct 19. pii: annrheumdis-2019-216169.
    PubMed     Abstract available


  72. FORNARO M, Cacciapaglia F, Venerito V, Lopalco G, et al
    Response to: 'Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al.
    Ann Rheum Dis. 2019 Oct 11. pii: annrheumdis-2019-216407.
    PubMed    


  73. LANDEWE RBM
    Response to: 'Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis' by Ferreira et al.
    Ann Rheum Dis. 2019;78:e110.
    PubMed    


  74. BUCH MH
    Response to 'Correspondence to viewpoint 'Defining refractory rheumatoid arthritis' by Buch' by Roodenrijs et al.
    Ann Rheum Dis. 2019;78:e106.
    PubMed    


  75. ROODENRIJS NM, de Hair MJ, van der Goes MC, Jacobs JW, et al
    Correspondence to viewpoint 'Defining refractory rheumatoid arthritis' by Buch.
    Ann Rheum Dis. 2019;78:e105.
    PubMed    


  76. RAVINDRAN V, Kataria S
    Digital health in rheumatology.
    Ann Rheum Dis. 2019;78:e103.
    PubMed    


  77. WOUTERS F, van der Giesen FJ, Matthijssen XME, Niemantsverdriet E, et al
    Difficulties making a fist in clinically suspect arthralgia: an easy applicable phenomenon predictive for RA that is related to flexor tenosynovitis.
    Ann Rheum Dis. 2019;78:1438-1439.
    PubMed    


    September 2019
  78. LIOU YS, Lin TK, Chen HY, Jong GP, et al
    Medications associated with fracture risk in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 Sep 17. pii: annrheumdis-2019-216262.
    PubMed    


  79. SAFIRI S, Kolahi AA, Hoy D, Smith E, et al
    Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017.
    Ann Rheum Dis. 2019 Sep 11. pii: annrheumdis-2019-215920.
    PubMed     Abstract available


  80. NOCTURNE G, Seror R, Mariette X
    Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands?
    Ann Rheum Dis. 2019;78:e95.
    PubMed    


  81. KAPSOGEORGOU EK, Papageorgiou A, Protogerou AD, Voulgarelis M, et al
    Response to: 'Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands?' by Nocturne et al.
    Ann Rheum Dis. 2019;78:e96.
    PubMed    


  82. BLUETT J, Riba-Garcia I, Verstappen SMM, Wendling T, et al
    Development and validation of a methotrexate adherence assay.
    Ann Rheum Dis. 2019;78:1192-1197.
    PubMed     Abstract available


  83. LOH C, Park SH, Lee A, Yuan R, et al
    TNF-induced inflammatory genes escape repression in fibroblast-like synoviocytes: transcriptomic and epigenomic analysis.
    Ann Rheum Dis. 2019;78:1205-1214.
    PubMed     Abstract available


  84. DERVIEUX T, Kremer JM, Weinblatt ME
    Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept.
    Ann Rheum Dis. 2019;78:1285-1286.
    PubMed    


    August 2019
  85. KISSEL T, van Schie KA, Hafkenscheid L, Lundquist A, et al
    On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritis.
    Ann Rheum Dis. 2019 Aug 30. pii: annrheumdis-2019-215698.
    PubMed     Abstract available


  86. SONG G, Feng T, Zhao R, Lu Q, et al
    CD109 regulates the inflammatory response and is required for the pathogenesis of rheumatoid arthritis.
    Ann Rheum Dis. 2019 Aug 27. pii: annrheumdis-2019-215473.
    PubMed     Abstract available


  87. ALETAHA D, Maa JF, Chen S, Park SH, et al
    Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 Aug 21. pii: annrheumdis-2018-214918.
    PubMed     Abstract available


  88. PUTRIK P, Ramiro S, Guillemin F, Pentek M, et al
    Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries.
    Ann Rheum Dis. 2019 Aug 19. pii: annrheumdis-2019-215294.
    PubMed     Abstract available


  89. BOETERS DM, Burgers LE, Toes RE, van der Helm-van Mil A, et al
    Does immunological remission, defined as disappearance of autoantibodies, occur with current treatment strategies? A long-term follow-up study in rheumatoid arthritis patients who achieved sustained DMARD-free status.
    Ann Rheum Dis. 2019 Aug 14. pii: annrheumdis-2018-214868.
    PubMed     Abstract available


  90. AGCA R, Heslinga SC, Rollefstad S, Heslinga S, et al
    Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al.
    Ann Rheum Dis. 2019 Aug 14. pii: annrheumdis-2019-215748.
    PubMed    


  91. LIU YT, Tsou HK, Chiou JY, Wang YH, et al
    Association of human papillomavirus infection with risk for rheumatoid arthritis: a population-based cohort study.
    Ann Rheum Dis. 2019 Aug 14. pii: annrheumdis-2019-215931.
    PubMed    


  92. RODRIGUEZ-UBREVA J, de la Calle-Fabregat C, Li T, Ciudad L, et al
    Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis.
    Ann Rheum Dis. 2019 Aug 1. pii: annrheumdis-2019-215355.
    PubMed     Abstract available


  93. ROGER A, Groh M, Lorillon G, Le Pendu C, et al
    Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors.
    Ann Rheum Dis. 2019;78:e82.
    PubMed    


    July 2019
  94. WALLACE BI, Wallace DM, Waljee AK, Clauw DJ, et al
    Evidence to support or guide glucocorticoid tapering in rheumatoid arthritis is lacking.
    Ann Rheum Dis. 2019 Jul 31. pii: annrheumdis-2019-216009.
    PubMed    


  95. FLEISCHMANN RM, Genovese MC, Enejosa JV, Mysler E, et al
    Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response.
    Ann Rheum Dis. 2019 Jul 30. pii: annrheumdis-2019-215764.
    PubMed     Abstract available


  96. TANAKA Y, Takeuchi T, Tanaka S, Kawakami A, et al
    Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3).
    Ann Rheum Dis. 2019 Jul 26. pii: annrheumdis-2019-215163.
    PubMed     Abstract available


  97. TAKEUCHI T, Tanaka Y, Tanaka S, Kawakami A, et al
    Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan.
    Ann Rheum Dis. 2019 Jul 26. pii: annrheumdis-2019-215164.
    PubMed     Abstract available


  98. HUMBY F, Lewis M, Townsend MJ, Pitzalis C, et al
    Response to 'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients' by Humby et al.
    Ann Rheum Dis. 2019 Jul 13. pii: annrheumdis-2019-215903.
    PubMed    


  99. BUCH MH, Melville A, McGonagle DG
    Response to: 'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients' by Humby et al.
    Ann Rheum Dis. 2019 Jul 13. pii: annrheumdis-2019-215881.
    PubMed    


  100. LAI SW, Kuo YH, Liao KF
    Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 Jul 12. pii: annrheumdis-2019-215982.
    PubMed    


  101. XIE W, Xiao S, Zhang Z
    Response to: 'Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials' by Lee and Song.
    Ann Rheum Dis. 2019 Jul 4. pii: annrheumdis-2019-215841.
    PubMed    


  102. ARNAUD L, Lebrun-Vignes B, Salem JE
    Checkpoint inhibitor-associated immune arthritis.
    Ann Rheum Dis. 2019;78:e68.
    PubMed    


  103. KAMPSTRA ASB, Dekkers JS, Volkov M, Dorjee AL, et al
    Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification.
    Ann Rheum Dis. 2019;78:908-916.
    PubMed     Abstract available


  104. JOUSSE-JOULIN S, D'Agostino MA, Nicolas C, Naredo E, et al
    Video clip assessment of a salivary gland ultrasound scoring system in Sjogren's syndrome using consensual definitions: an OMERACT ultrasound working group reliability exercise.
    Ann Rheum Dis. 2019;78:967-973.
    PubMed     Abstract available


  105. BITOUN S, Roques P, Maillere B, Le Grand R, et al
    Valine 11 and phenylalanine 13 have a greater impact on the T-cell response to citrullinated peptides than the 70-74 shared epitope of the DRB1 molecule in macaques.
    Ann Rheum Dis. 2019;78:917-921.
    PubMed     Abstract available


  106. WIECZOREK G, Bigaud M, Pfister S, Ceci M, et al
    Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjogren's syndrome.
    Ann Rheum Dis. 2019;78:974-978.
    PubMed     Abstract available


    June 2019
  107. POLLASTRO S, Klarenbeek PL, Doorenspleet ME, van Schaik BDC, et al
    Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire.
    Ann Rheum Dis. 2019 Jun 19. pii: annrheumdis-2018-214898.
    PubMed     Abstract available


  108. HILLION J, Bellier A, Romand X, Fautrel B, et al
    Alcohol is not the missing link between Porphyromonas gingivalis-related periodontitis and radiological progression in early rheumatoid arthritis: comment on 'Porphyromonas gingivalis experimentally induces periodontitis and an anti-CCP2-associated ar
    Ann Rheum Dis. 2019 Jun 14. pii: annrheumdis-2019-215603.
    PubMed    


  109. VERHOEVEN MM, de Hair MJ, Tekstra J, Bijlsma JW, et al
    Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAME
    Ann Rheum Dis. 2019 Jun 13. pii: annrheumdis-2019-215304.
    PubMed     Abstract available


  110. LEE YH, Song GG
    Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials.
    Ann Rheum Dis. 2019 Jun 11. pii: annrheumdis-2019-215815.
    PubMed    


  111. GLATT S, Taylor PC, McInnes IB, Schett G, et al
    Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study.
    Ann Rheum Dis. 2019 Jun 8. pii: annrheumdis-2018-214943.
    PubMed     Abstract available


  112. HAMMER HB, Michelsen B, Sexton J, Haugen IK, et al
    Swollen, but not tender joints, are independently associated with ultrasound synovitis: results from a longitudinal observational study of patients with established rheumatoid arthritis.
    Ann Rheum Dis. 2019 Jun 6. pii: annrheumdis-2019-215321.
    PubMed     Abstract available


  113. TAKESHITA M, Suzuki K, Kondo Y, Morita R, et al
    Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell.
    Ann Rheum Dis. 2019 Jun 5. pii: annrheumdis-2018-214885.
    PubMed     Abstract available


  114. TOES R, Pisetsky DS
    Pathogenic effector functions of ACPA: Where do we stand?
    Ann Rheum Dis. 2019;78:716-721.
    PubMed    


  115. PISETSKY DS, Spencer DM, Lipsky PE, Rovin BH, et al
    Response to: 'Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: the positive experience of a national multi-center study' by Pregnalato et al.
    Ann Rheum Dis. 2019;78:e51.
    PubMed    


  116. PISETSKY DS, Spencer DM, Lipsky PE, Rovin BH, et al
    Response to: 'Variation in antinuclear antibody detection by automated indirect immunofluorescence analysis' by van Hoovels et al.
    Ann Rheum Dis. 2019;78:e49.
    PubMed    


  117. MANOLIOS N, Schrieber L
    Checkpoint inhibitors and arthritis.
    Ann Rheum Dis. 2019;78:e58.
    PubMed    


  118. CAMBRE I, Gaublomme D, Schryvers N, Lambrecht S, et al
    Running promotes chronicity of arthritis by local modulation of complement activators and impairing T regulatory feedback loops.
    Ann Rheum Dis. 2019;78:787-795.
    PubMed     Abstract available


  119. MANKIA K, D'Agostino MA, Rowbotham E, Hensor EM, et al
    MRI inflammation of the hand interosseous tendons occurs in anti-CCP-positive at-risk individuals and may precede the development of clinical synovitis.
    Ann Rheum Dis. 2019;78:781-786.
    PubMed     Abstract available


    May 2019
  120. SUGIYAMA T
    Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 May 31. pii: annrheumdis-2019-215747.
    PubMed    


  121. FORNARO M, Cacciapaglia F, Venerito V, Lopalco G, et al
    Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients.
    Ann Rheum Dis. 2019 May 29. pii: annrheumdis-2019-215715.
    PubMed    


  122. INCE-ASKAN H, Mandaviya PR, Felix JF, Duijts L, et al
    Altered DNA methylation in children born to mothers with rheumatoid arthritis during pregnancy.
    Ann Rheum Dis. 2019 May 29. pii: annrheumdis-2018-214930.
    PubMed     Abstract available


  123. FINZEL S, Kraus S, Figueiredo CP, Regensburger A, et al
    Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis.
    Ann Rheum Dis. 2019 May 29. pii: annrheumdis-2018-214894.
    PubMed     Abstract available


  124. MOTEGI T, Kochi Y, Matsuda K, Kubo M, et al
    Identification of rare coding variants in TYK2 protective for rheumatoid arthritis in the Japanese population and their effects on cytokine signalling.
    Ann Rheum Dis. 2019 May 22. pii: annrheumdis-2019-215062.
    PubMed     Abstract available


  125. MANKIA K, D'Agostino MA, Murillo-Gonzalez J, Grainger A, et al
    Response to: 'Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?' by Deng et al.
    Ann Rheum Dis. 2019 May 17. pii: annrheumdis-2019-215611.
    PubMed    


  126. LIU X, Zhang W, Zhao M, Fu L, et al
    T cell receptor beta repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis.
    Ann Rheum Dis. 2019 May 17. pii: annrheumdis-2019-215442.
    PubMed     Abstract available


  127. DENG Z, Liu H, Lu W
    Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?
    Ann Rheum Dis. 2019 May 17. pii: annrheumdis-2019-215559.
    PubMed    


  128. OZEN G, Pedro S, Wolfe F, Michaud K, et al
    Medications associated with fracture risk in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 May 15. pii: annrheumdis-2019-215328.
    PubMed     Abstract available


  129. XIE W, Huang Y, Xiao S, Sun X, et al
    Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials.
    Ann Rheum Dis. 2019 May 14. pii: annrheumdis-2018-214846.
    PubMed     Abstract available


  130. L'AMI MJ, Krieckaert CL, Nurmohamed MT, van Vollenhoven RF, et al
    Response to: 'Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from the STRASS study' by Marotte et al.
    Ann Rheum Dis. 2019 May 9. pii: annrheumdis-2019-215609.
    PubMed    


  131. MAROTTE H, Rinaudo-Gaujous M, Petiet C, Fautrel B, et al
    Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from STRASS study.
    Ann Rheum Dis. 2019 May 2. pii: annrheumdis-2019-215546.
    PubMed    


  132. DORNER T, Posch MG, Li Y, Petricoul O, et al
    Treatment of primary Sjogren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.
    Ann Rheum Dis. 2019;78:641-647.
    PubMed     Abstract available


  133. BOTTINI A, Wu DJ, Ai R, Le Roux M, et al
    PTPN14 phosphatase and YAP promote TGFbeta signalling in rheumatoid synoviocytes.
    Ann Rheum Dis. 2019;78:600-609.
    PubMed     Abstract available


  134. VAN DER MEULEN TA, van Nimwegen JF, Harmsen HJM, Liefers SC, et al
    Normal vaginal microbiome in women with primary Sjogren's syndrome-associated vaginal dryness.
    Ann Rheum Dis. 2019;78:707-709.
    PubMed    


    April 2019
  135. TANAKA Y, Fautrel B, Keystone EC, Ortmann RA, et al
    Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 Apr 30. pii: annrheumdis-2018-214529.
    PubMed     Abstract available


  136. TAKEUCHI T, Tanaka Y, Soen S, Yamanaka H, et al
    Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled p
    Ann Rheum Dis. 2019 Apr 29. pii: annrheumdis-2018-214827.
    PubMed     Abstract available


  137. SPILIOPOULOU A, Colombo M, Plant D, Nair N, et al
    Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39.
    Ann Rheum Dis. 2019 Apr 29. pii: annrheumdis-2018-214877.
    PubMed     Abstract available


  138. SWEET K, Dasgupta B, de Vries D, Gourley I, et al
    Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial.
    Ann Rheum Dis. 2019 Apr 24. pii: annrheumdis-2019-215183.
    PubMed    


  139. VAN MULLIGEN E, de Jong PHP, Kuijper TM, van der Ven M, et al
    Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study.
    Ann Rheum Dis. 2019 Apr 6. pii: annrheumdis-2018-214970.
    PubMed     Abstract available


  140. GUO J, Zhang T, Cao H, Li X, et al
    Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population.
    Ann Rheum Dis. 2019 Apr 1. pii: annrheumdis-2018-214725.
    PubMed     Abstract available


  141. FISHER BA, Emery P, Pitzalis C, Bombardieri M, et al
    Response to: Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjogren's syndrome?
    Ann Rheum Dis. 2019;78:e28.
    PubMed    


  142. SCHERLINGER M, Schaeverbeke T
    Additional response to the correspondence: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Cantini and Bennuci.
    Ann Rheum Dis. 2019;78:e26.
    PubMed    


  143. MOSSEL E, Delli K, Arends S, Haacke EA, et al
    Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjogren's syndrome?
    Ann Rheum Dis. 2019;78:e27.
    PubMed    


  144. HEWLETT S, Almeida C, Ambler N, Blair PS, et al
    Reducing arthritis fatigue impact: two-year randomised controlled trial of cognitive behavioural approaches by rheumatology teams (RAFT).
    Ann Rheum Dis. 2019;78:465-472.
    PubMed     Abstract available


    March 2019
  145. PARK JK, Choi Y, Winthrop KL, Song YW, et al
    Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial.
    Ann Rheum Dis. 2019 Mar 23. pii: annrheumdis-2019-215187.
    PubMed    


  146. VISVANATHAN S, Daniluk S, Ptaszynski R, Muller-Ladner U, et al
    Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker parameters in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study.
    Ann Rheum Dis. 2019 Mar 22. pii: annrheumdis-2018-214729.
    PubMed     Abstract available



  147. Correction: Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss.
    Ann Rheum Dis. 2019 Mar 18. pii: annrheumdis-2015-208093.
    PubMed    


  148. HUMBY F, Lewis M, Ramamoorthi N, Hackney JA, et al
    Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.
    Ann Rheum Dis. 2019 Mar 16. pii: annrheumdis-2018-214539.
    PubMed     Abstract available


  149. FENT G, Mankia K, Erhayiem B, Hunt L, et al
    First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis.
    Ann Rheum Dis. 2019 Mar 9. pii: annrheumdis-2018-214975.
    PubMed    


  150. COMBE B, Balsa A, Sarzi-Puttini P, Tony HP, et al
    Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib.
    Ann Rheum Dis. 2019 Mar 6. pii: annrheumdis-2018-214261.
    PubMed    


  151. HUA C, Rempenault C, Combe B
    Response to: 'Metabolic and cardiovascular benefits of hydroxychloroquine: exploration in a wider population at high CV risk' by Pareek et al.
    Ann Rheum Dis. 2019;78:e22.
    PubMed    


  152. ACOSTA-HERRERA M, Kerick M, Gonzalez-Serna D, Wijmenga C, et al
    Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases.
    Ann Rheum Dis. 2019;78:311-319.
    PubMed     Abstract available


  153. ATERIDO A, Canete JD, Tornero J, Ferrandiz C, et al
    Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis.
    Ann Rheum Dis. 2019;78.
    PubMed     Abstract available


  154. KIM K
    Massive false-positive gene-gene interactions by Rothman's additive model.
    Ann Rheum Dis. 2019;78:437-439.
    PubMed    


    February 2019
  155. POPPELAARS PB, van Tuyl LHD, Boers M
    Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up.
    Ann Rheum Dis. 2019 Feb 26. pii: annrheumdis-2018-214618.
    PubMed     Abstract available


  156. WESTERLIND H, Holmqvist M, Ljung L, Frisell T, et al
    Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome.
    Ann Rheum Dis. 2019 Feb 20. pii: annrheumdis-2018-214828.
    PubMed     Abstract available


  157. ALPIZAR-RODRIGUEZ D, Lesker TR, Gronow A, Gilbert B, et al
    Prevotella copri in individuals at risk for rheumatoid arthritis.
    Ann Rheum Dis. 2019 Feb 13. pii: annrheumdis-2018-214514.
    PubMed     Abstract available


  158. CUTOLO M, Soldano S, Paolino S
    Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis.
    Ann Rheum Dis. 2019 Feb 1. pii: annrheumdis-2019-215063.
    PubMed    


  159. AUNGIER SR, Cartwright AJ, Schwenzer A, Marshall JL, et al
    Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?
    Ann Rheum Dis. 2019;78:186-191.
    PubMed     Abstract available


  160. NAYAR S, Campos J, Smith CG, Iannizzotto V, et al
    Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjogren's syndrome.
    Ann Rheum Dis. 2019;78:249-260.
    PubMed     Abstract available


  161. GLINTBORG B, Loft AG, Omerovic E, Hendricks O, et al
    To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.
    Ann Rheum Dis. 2019;78:192-200.
    PubMed     Abstract available


  162. VALENZUELA O, Ibanez Vodnizza SE
    How to reduce the waiting time for the first consultation with the rheumatologist as a first step for a timely treatment.
    Ann Rheum Dis. 2019;78:279.
    PubMed    


    January 2019
  163. PAWAR A, Desai RJ, Solomon DH, Santiago Ortiz AJ, et al
    Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.
    Ann Rheum Dis. 2019 Jan 24. pii: annrheumdis-2018-214367.
    PubMed     Abstract available


  164. NORGARD BM, Larsen MD, Friedman S, Knudsen T, et al
    Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort study.
    Ann Rheum Dis. 2019 Jan 12. pii: annrheumdis-2018-214619.
    PubMed     Abstract available


  165. GRON KL, Arkema EV, Glintborg B, Mehnert F, et al
    Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden.
    Ann Rheum Dis. 2019 Jan 5. pii: annrheumdis-2018-214326.
    PubMed     Abstract available


  166. BURGGRAAF B, van Breukelen-van der Stoep DF, de Vries MA, Klop B, et al
    Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial.
    Ann Rheum Dis. 2019 Jan 4. pii: annrheumdis-2018-214075.
    PubMed     Abstract available


  167. CHEN YM, Huang WN, Liao TL, Chen JP, et al
    Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy.
    Ann Rheum Dis. 2019 Jan 3. pii: annrheumdis-2018-214400.
    PubMed    


  168. MANKIA K, D'Agostino MA, Wakefield RJ, Nam JL, et al
    Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism.
    Ann Rheum Dis. 2019;78:43-50.
    PubMed     Abstract available


  169. DEN BROEDER N, Bouman CAM, Kievit W, van Herwaarden N, et al
    Three-year cost-effectiveness analysis of the DRESS study: protocolised tapering is key.
    Ann Rheum Dis. 2019;78:141-142.
    PubMed    


  170. MICHELSEN B, Kvien TK
    Response to: 'Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis' by Boer et al.
    Ann Rheum Dis. 2019;78:e2.
    PubMed    


    December 2018
  171. OKADA Y, Eyre S, Suzuki A, Kochi Y, et al
    Genetics of rheumatoid arthritis: 2018 status.
    Ann Rheum Dis. 2018 Dec 8. pii: annrheumdis-2018-213678.
    PubMed     Abstract available


  172. GERLAG DM, Safy M, Maijer KI, Tang MW, et al
    Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study.
    Ann Rheum Dis. 2018 Dec 1. pii: annrheumdis-2017-212763.
    PubMed     Abstract available


    October 2018
  173. BERGSTRA SA, Winchow LL, Murphy E, Chopra A, et al
    How to treat patients with rheumatoid arthritis when methotrexate has failed? The use of a multiple propensity score to adjust for confounding by indication in observational studies.
    Ann Rheum Dis. 2018 Oct 16. pii: annrheumdis-2018-213731.
    PubMed     Abstract available


  174. SINGH JA
    Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: reality or dream?
    Ann Rheum Dis. 2018 Oct 9. pii: annrheumdis-2018-213694.
    PubMed    


  175. ZHU H, Wu LF, Mo XB, Lu X, et al
    Rheumatoid arthritis-associated DNA methylation sites in peripheral blood mononuclear cells.
    Ann Rheum Dis. 2018 Oct 8. pii: annrheumdis-2018-213970.
    PubMed     Abstract available


  176. PARK JK, Lee YJ, Bitoun S, Winthrop KL, et al
    Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Oct 8. pii: annrheumdis-2018-214025.
    PubMed    


  177. MARTINEZ-PRAT L, Lucia D, Ibarra C, Mahler M, et al
    Antibodies targeting protein-arginine deiminase 4 (PAD4) demonstrate diagnostic value in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Oct 8. pii: annrheumdis-2018-213818.
    PubMed    


    September 2018
  178. DIEKHOFF T, Ulas ST, Poddubnyy D, Schneider U, et al
    Ultra-low-dose CT detects synovitis in patients with suspected rheumatoid arthritis.
    Ann Rheum Dis. 2018 Sep 29. pii: annrheumdis-2018-213904.
    PubMed     Abstract available


  179. TSUJI H, Ikari K, Ohmura K, Yano K, et al
    Significant joint-destructive association of HLA-DRB1*04:05 independent of DAS28 in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Sep 19. pii: annrheumdis-2018-214022.
    PubMed    


  180. TAKEUCHI T, Genovese MC, Haraoui B, Li Z, et al
    Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study.
    Ann Rheum Dis. 2018 Sep 7. pii: annrheumdis-2018-213271.
    PubMed     Abstract available


  181. ROODENRIJS NMT, de Hair MJH, van der Goes MC, Jacobs JWG, et al
    Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey.
    Ann Rheum Dis. 2018 Sep 7. pii: annrheumdis-2018-213687.
    PubMed     Abstract available


    August 2018
  182. TEITSMA XM, Jacobs JWG, de Jong PHP, Hazes JMW, et al
    Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis.
    Ann Rheum Dis. 2018 Aug 29. pii: annrheumdis-2018-213767.
    PubMed    


  183. RIVELLESE F, Mauro D, Nerviani A, Pagani S, et al
    Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production.
    Ann Rheum Dis. 2018 Aug 20. pii: annrheumdis-2018-213418.
    PubMed     Abstract available


  184. FERREIRA RJO, Ndosi M, de Wit M, Santos EJF, et al
    Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Aug 20. pii: annrheumdis-2018-214199.
    PubMed    


  185. VAN DELFT MAM, van der Woude D, Toes REM, Trouw LA, et al
    Secretory form of rheumatoid arthritis-associated autoantibodies in serum are mainly of the IgM isotype, suggesting a continuous reactivation of autoantibody responses at mucosal surfaces.
    Ann Rheum Dis. 2018 Aug 14. pii: annrheumdis-2018-213724.
    PubMed    


  186. LANDEWE RBM
    Response to: 'Early identification of rheumatoid arthritis; the risk of overtreatment in perspective' by Landewe.
    Ann Rheum Dis. 2018 Aug 10. pii: annrheumdis-2018-214172.
    PubMed    


  187. VAN DER HELM-VAN MIL A
    Early identification of rheumatoid arthritis: the risk of overtreatment in perspective.
    Ann Rheum Dis. 2018 Aug 10. pii: annrheumdis-2018-214156.
    PubMed    


  188. SMOLEN JS, van Vollenhoven RF, Florentinus S, Chen S, et al
    Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate.
    Ann Rheum Dis. 2018 Aug 3. pii: annrheumdis-2018-213502.
    PubMed     Abstract available


    July 2018
  189. BUSTAMANTE MF, Oliveira PG, Garcia-Carbonell R, Croft AP, et al
    Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 30. pii: annrheumdis-2018-213103.
    PubMed     Abstract available


  190. JIN S, Chen H, Li Y, Zhong H, et al
    Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21.
    Ann Rheum Dis. 2018 Jul 25. pii: annrheumdis-2018-213511.
    PubMed     Abstract available


  191. BITOUN S, Miceli-Richard C, Verstuyft C, Juge PA, et al
    Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications.
    Ann Rheum Dis. 2018 Jul 20. pii: annrheumdis-2018-213183.
    PubMed    


  192. JANS L, De Kock I, Herregods N, Verstraete KL, et al
    Response to: 'The use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?' by Wu et al.
    Ann Rheum Dis. 2018 Jul 12. pii: annrheumdis-2018-213960.
    PubMed    


  193. WU H, Zhang G, Huang X, Liang C, et al
    Use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?
    Ann Rheum Dis. 2018 Jul 12. pii: annrheumdis-2018-213892.
    PubMed    


  194. LEE JY, Kang MJ, Choi JY, Park JS, et al
    Apolipoprotein B binds to enolase-1 and aggravates inflammation in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 11. pii: annrheumdis-2018-213444.
    PubMed     Abstract available


  195. NEUMANN E, Schwarz MC, Hasseli R, Hulser ML, et al
    Tetraspanin CD82 affects migration, attachment and invasion of rheumatoid arthritis synovial fibroblasts.
    Ann Rheum Dis. 2018 Jul 6. pii: annrheumdis-2018-212954.
    PubMed     Abstract available


  196. KEARSLEY-FLEET L, Davies R, De Cock D, Watson KD, et al
    Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Ann Rheum Dis. 2018 Jul 6. pii: annrheumdis-2018-213378.
    PubMed     Abstract available


  197. DIAZ-GALLO LM, Ramskold D, Shchetynsky K, Folkersen L, et al
    Systematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 2. pii: annrheumdis-2018-213412.
    PubMed     Abstract available


    June 2018
  198. PAULSHUS SUNDLISAETER N, Aga AB, Olsen IC, Hammer HB, et al
    Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes.
    Ann Rheum Dis. 2018 Jun 22. pii: annrheumdis-2017-212830.
    PubMed     Abstract available


  199. SOHRABIAN A, Mathsson-Alm L, Hansson M, Knight A, et al
    Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jun 12. pii: annrheumdis-2017-212627.
    PubMed     Abstract available


  200. FILIPPOU G, Sakellariou G, Scire CA, Carrara G, et al
    The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the
    Ann Rheum Dis. 2018 Jun 9. pii: annrheumdis-2018-213217.
    PubMed     Abstract available


  201. HILLIQUIN S, Hugues B, Mitrovic S, Gossec L, et al
    Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis.
    Ann Rheum Dis. 2018 Jun 8. pii: annrheumdis-2017-212612.
    PubMed     Abstract available


  202. MICHELSEN B, Uhlig T, Sexton J, van der Heijde D, et al
    Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.
    Ann Rheum Dis. 2018 Jun 6. pii: annrheumdis-2018-213286.
    PubMed     Abstract available


    May 2018
  203. KANEKO Y, Kato M, Tanaka Y, Inoo M, et al
    Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SUR
    Ann Rheum Dis. 2018 May 31. pii: annrheumdis-2018-213416.
    PubMed     Abstract available


  204. TEITSMA XM, Jacobs JWG, Welsing PMJ, de Jong PHP, et al
    Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.
    Ann Rheum Dis. 2018 May 14. pii: annrheumdis-2018-213035.
    PubMed     Abstract available


  205. LAUPER K, Nordstrom DC, Pavelka K, Hernandez MV, et al
    Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modi
    Ann Rheum Dis. 2018 May 5. pii: annrheumdis-2017-212845.
    PubMed     Abstract available


  206. HEDSTROM AK, Klareskog L, Alfredsson L
    Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study.
    Ann Rheum Dis. 2018 May 3. pii: annrheumdis-2018-212973.
    PubMed     Abstract available


  207. MUNICIO C, Dominguez-Soto A, Fuentelsaz-Romero S, Lamana A, et al
    Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.
    Ann Rheum Dis. 2018;77:752-759.
    PubMed     Abstract available


  208. FRISELL T, Baecklund E, Bengtsson K, Di Giuseppe D, et al
    Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.
    Ann Rheum Dis. 2018;77:650-657.
    PubMed     Abstract available


  209. PISETSKY DS
    How the gut inflames the joints.
    Ann Rheum Dis. 2018;77:634-635.
    PubMed    


  210. WINTHROP KL, Baddley JW
    Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question.
    Ann Rheum Dis. 2018;77:631-633.
    PubMed    


    April 2018
  211. BOER AC, Boeters DM, van der Helm-van Mil AHM
    The use of MRI-detected synovitis to determine the number of involved joints for the 2010 ACR/EULAR classification criteria for Rheumatoid Arthritis - is it of additional benefit?
    Ann Rheum Dis. 2018 Apr 20. pii: annrheumdis-2018-213143.
    PubMed     Abstract available


  212. CHEN YM, Liao TL, Chen HH, Chen DY, et al
    Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Apr 19. pii: annrheumdis-2018-213097.
    PubMed    


  213. SANTOS EJF, Duarte C, Ferreira RJO, Pinto AM, et al
    Determinants of happiness and quality of life in patients with rheumatoid arthritis: a structural equation modelling approach.
    Ann Rheum Dis. 2018 Apr 6. pii: annrheumdis-2017-212934.
    PubMed     Abstract available


  214. BONDT A, Hafkenscheid L, Falck D, Kuijper TM, et al
    ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Apr 3. pii: annrheumdis-2018-212946.
    PubMed     Abstract available


  215. MOSSEL E, Arends S, van Nimwegen JF, Delli K, et al
    Scoring hypoechogenic areas in one parotid and one submandibular gland increases feasibility of ultrasound in primary Sjogren's syndrome.
    Ann Rheum Dis. 2018;77:556-562.
    PubMed     Abstract available


  216. DAIEN CI, Tubery A, Cailar GD, Mura T, et al
    Application of the 2015/2016 EULAR recommendations for cardiovascular risk in daily practice: data from an observational study.
    Ann Rheum Dis. 2018;77:625-626.
    PubMed    


  217. MULLEMAN D, Balsa A
    Adalimumab concentration-based tapering strategy: as good as the recommended dosage.
    Ann Rheum Dis. 2018;77:473-475.
    PubMed    


    March 2018
  218. RUTHERFORD AI, Subesinghe S, Hyrich KL, Galloway JB, et al
    Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatolgy Biologics Register for Rheumatoid Arthritis.
    Ann Rheum Dis. 2018 Mar 28. pii: annrheumdis-2017-212825.
    PubMed     Abstract available


  219. BUCH MH
    Defining refractory rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 27. pii: annrheumdis-2017-212862.
    PubMed     Abstract available


  220. PARK JK, Lee YJ, Shin K, Ha YJ, et al
    Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Ann Rheum Dis. 2018 Mar 23. pii: annrheumdis-2018-213222.
    PubMed     Abstract available


  221. COHEN SB, Alonso-Ruiz A, Klimiuk PA, Lee EC, et al
    Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study.
    Ann Rheum Dis. 2018 Mar 7. pii: annrheumdis-2017-212245.
    PubMed     Abstract available


  222. LEONARD D, Svenungsson E, Dahlqvist J, Alexsson A, et al
    Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 7. pii: annrheumdis-2017-212614.
    PubMed     Abstract available


  223. GADEHOLT O
    Forward to the past: ultrasound might be necessary in some patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 6. pii: annrheumdis-2018-213278.
    PubMed    


  224. JANS L, De Kock I, Herregods N, Verstraete K, et al
    Dual-energy CT: a new imaging modality for bone marrow oedema in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 1. pii: annrheumdis-2018-213152.
    PubMed    


  225. JUST SA, Rostgaard K, Titlestad K, Edgren G, et al
    Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study.
    Ann Rheum Dis. 2018 Mar 1. pii: annrheumdis-2017-212844.
    PubMed    


  226. FISHER BA, Everett CC, Rout J, O'Dwyer JL, et al
    Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.
    Ann Rheum Dis. 2018;77:412-416.
    PubMed     Abstract available


    February 2018
  227. TAYLOR PC, Schiff MH, Wang Q, Jiang Y, et al
    Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naive patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study.
    Ann Rheum Dis. 2018 Feb 26. pii: annrheumdis-2017-212496.
    PubMed     Abstract available


  228. STEMMLER F, Simon D, Liphardt AM, Englbrecht M, et al
    Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures.
    Ann Rheum Dis. 2018 Feb 23. pii: annrheumdis-2017-212404.
    PubMed     Abstract available


  229. LI HZ, Xu XH, Lin N, Lu HD, et al
    Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Ann Rheum Dis. 2018 Feb 16. pii: annrheumdis-2018-213157.
    PubMed    


  230. DE PABLO P, Romaguera D, Fisk HL, Calder PC, et al
    High erythrocyte levels of the n-6 polyunsaturated fatty acid linoleic acid are associated with lower risk of subsequent rheumatoid arthritis in a southern European nested case-control study.
    Ann Rheum Dis. 2018 Feb 7. pii: annrheumdis-2017-212274.
    PubMed     Abstract available


  231. ZEISBRICH M, Yanes RE, Zhang H, Watanabe R, et al
    Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation.
    Ann Rheum Dis. 2018 Feb 3. pii: annrheumdis-2017-212647.
    PubMed     Abstract available


    January 2018
  232. VAN HOOVELS L, Jacobs J, Vander Cruyssen B, Van den Bremt S, et al
    Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 23. pii: annrheumdis-2017-212365.
    PubMed     Abstract available


  233. VAN VOLLENHOVEN RF, Keystone EC, Strand V, Pacheco-Tena C, et al
    Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.
    Ann Rheum Dis. 2018 Jan 17. pii: annrheumdis-2017-212478.
    PubMed     Abstract available


  234. CHEVREAU M, Paclet MH, Romand X, Quesada JL, et al
    Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis. Comment on 'Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis' by Jonsson et al.
    Ann Rheum Dis. 2018 Jan 10. pii: annrheumdis-2017-212816.
    PubMed    


  235. BOER AC, Huizinga TWJ, van der Helm-van Mil AHM
    Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 8. pii: annrheumdis-2017-212867.
    PubMed    


  236. RADNER H, Chatzidionysiou K, Nikiphorou E, Gossec L, et al
    2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 4. pii: annrheumdis-2017-212256.
    PubMed     Abstract available


  237. AKDEMIR G, Heimans L, Bergstra SA, Goekoop RJ, et al
    Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study.
    Ann Rheum Dis. 2018;77:111-118.
    PubMed     Abstract available


  238. SCHONAU V, Vogel K, Englbrecht M, Wacker J, et al
    The value of (18)F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study.
    Ann Rheum Dis. 2018;77:70-77.
    PubMed     Abstract available


  239. WANG-RENAULT SF, Boudaoud S, Nocturne G, Roche E, et al
    Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjogren's syndrome.
    Ann Rheum Dis. 2018;77:133-140.
    PubMed     Abstract available


    December 2017
  240. CURTIS JR, Xie F, Chen L, Saag KG, et al
    Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study.
    Ann Rheum Dis. 2017 Dec 21. pii: annrheumdis-2017-211727.
    PubMed     Abstract available


  241. MATSUNO H, Tomomitsu M, Hagino A, Shin S, et al
    Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding
    Ann Rheum Dis. 2017 Dec 19. pii: annrheumdis-2017-212172.
    PubMed     Abstract available


  242. FRAENKEL L, Nowell WB, Michel G, Wiedmeyer C, et al
    Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Dec 15. pii: annrheumdis-2017-212407.
    PubMed     Abstract available


  243. CORDTZ RL, Hawley S, Prieto-Alhambra D, Hojgaard P, et al
    Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers.
    Ann Rheum Dis. 2017 Dec 15. pii: annrheumdis-2017-212424.
    PubMed     Abstract available


  244. DREYER L, Cordtz RL, Hansen IMJ, Kristensen LE, et al
    Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study.
    Ann Rheum Dis. 2017 Dec 7. pii: annrheumdis-2017-212086.
    PubMed     Abstract available


  245. GAUJOUX-VIALA C, Rincheval N, Dougados M, Combe B, et al
    Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort.
    Ann Rheum Dis. 2017;76:2054-2060.
    PubMed     Abstract available


  246. TSUBOI H, Hagiwara S, Asashima H, Takahashi H, et al
    Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjogren's syndrome with other sets of criteria in Japanese patients.
    Ann Rheum Dis. 2017;76:1980-1985.
    PubMed     Abstract available


    November 2017
  247. SMILJANOVIC B, Radzikowska A, Kuca-Warnawin E, Kurowska W, et al
    Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint.
    Ann Rheum Dis. 2017 Nov 30. pii: annrheumdis-2017-211649.
    PubMed     Abstract available


  248. HENAUX S, Ruyssen-Witrand A, Cantagrel A, Barnetche T, et al
    Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis.
    Ann Rheum Dis. 2017 Nov 29. pii: annrheumdis-2017-212423.
    PubMed     Abstract available


  249. WEIJERS JM, Rongen-van Dartel SAA, Hoevenaars DMGMF, Rubens M, et al
    Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care.
    Ann Rheum Dis. 2017 Nov 22. pii: annrheumdis-2017-212392.
    PubMed     Abstract available


  250. MO WX, Yin SS, Chen H, Zhang X, et al
    Amino-bisphosphonates, gammadeltaT cells, and their roles in Rheumatoid Arthritis.
    Ann Rheum Dis. 2017 Nov 17. pii: annrheumdis-2017-212569.
    PubMed    


  251. KAVANAUGH A, van Vollenhoven R, Fleischmann RM, Emery P, et al
    Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Nov 16. pii: annrheumdis-2017-211871.
    PubMed     Abstract available


  252. L'AMI MJ, Krieckaert CLM, Nurmohamed MT, van Vollenhoven RF, et al
    Response to: Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al.
    Ann Rheum Dis. 2017 Nov 13. pii: annrheumdis-2017-212602.
    PubMed    


  253. GOSSEC L, Chauvin P, Saraux A, Hudry C, et al
    Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire.
    Ann Rheum Dis. 2017 Nov 4. pii: annrheumdis-2017-212000.
    PubMed     Abstract available


  254. CORDTZ RL, Zobbe K, Hojgaard P, Kristensen LE, et al
    Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers.
    Ann Rheum Dis. 2017 Nov 2. pii: annrheumdis-2017-212339.
    PubMed     Abstract available


  255. MOSSEL E, Delli K, van Nimwegen JF, Stel AJ, et al
    Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:1883-1889.
    PubMed     Abstract available


  256. DEN BROEDER AA, van den Bemt BJF
    Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial'.
    Ann Rheum Dis. 2017 Nov 1. pii: annrheumdis-2017-212579.
    PubMed    


    October 2017
  257. ROSSINI M, Adami G, Viapiana O, Idolazzi L, et al
    Rheumatoid arthritis, gammadelta T cells and bisphosphonates.
    Ann Rheum Dis. 2017 Oct 26. pii: annrheumdis-2017-212510.
    PubMed    


  258. SHI J, Darrah E, Sims GP, Mustelin T, et al
    Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Oct 25. pii: annrheumdis-2017-211489.
    PubMed     Abstract available


  259. RONNELID J, Hansson M, Mathsson-Alm L, Cornillet M, et al
    Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants.
    Ann Rheum Dis. 2017 Oct 25. pii: annrheumdis-2017-211782.
    PubMed     Abstract available


  260. SMOLEN JS, Choe JY, Prodanovic N, Niebrzydowski J, et al
    Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition st
    Ann Rheum Dis. 2017 Oct 17. pii: annrheumdis-2017-211741.
    PubMed     Abstract available


  261. ERIKSSON K, Nise L, Alfredsson L, Catrina AI, et al
    Seropositivity combined with smoking is associated with increased prevalence of periodontitis in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Oct 6. pii: annrheumdis-2017-212091.
    PubMed    


  262. BRAUNER S, Folkersen L, Kvarnstrom M, Meisgen S, et al
    H1N1 vaccination in Sjogren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
    Ann Rheum Dis. 2017;76:1755-1763.
    PubMed     Abstract available


  263. HAACKE EA, van der Vegt B, Vissink A, Spijkervet FKL, et al
    Germinal centres in diagnostic labial gland biopsies of patients with primary Sjogren's syndrome are not predictive for parotid MALT lymphoma development.
    Ann Rheum Dis. 2017;76:1781-1784.
    PubMed     Abstract available


  264. BURGERS LE, van Steenbergen HW, Ten Brinck RM, Huizinga TW, et al
    Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis.
    Ann Rheum Dis. 2017;76:1751-1754.
    PubMed     Abstract available


    September 2017
  265. HOLMQVIST M, Ljung L, Askling J
    Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?
    Ann Rheum Dis. 2017 Sep 26. pii: annrheumdis-2017-212131.
    PubMed     Abstract available


  266. REMPENAULT C, Combe B, Barnetche T, Gaujoux-Viala C, et al
    Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Ann Rheum Dis. 2017 Sep 25. pii: annrheumdis-2017-211836.
    PubMed     Abstract available


  267. MORITA T, Fujimoto K, Shima Y, Ogata A, et al
    Minimal neonatal transfer of certolizumab pegol in a Japanese patient with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 22. pii: annrheumdis-2017-212366.
    PubMed    


  268. L'AMI MJ, Krieckaert CL, Nurmohamed MT, van Vollenhoven RF, et al
    Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial.
    Ann Rheum Dis. 2017 Sep 22. pii: annrheumdis-2017-211781.
    PubMed     Abstract available


  269. ROBERTSON J, Porter D, Sattar N, Packard CJ, et al
    Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 15. pii: annrheumdis-2017-211708.
    PubMed     Abstract available


  270. ZENG P, Chen Z, Klareskog L, Alfredsson L, et al
    Amount of smoking, duration of smoking cessation and their interaction with silica exposure in the risk of rheumatoid arthritis among males: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study.
    Ann Rheum Dis. 2017 Sep 15. pii: annrheumdis-2017-212145.
    PubMed    


  271. CROWSON CS, Rollefstad S, Ikdahl E, Kitas GD, et al
    Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 6. pii: annrheumdis-2017-211735.
    PubMed     Abstract available


  272. MO WX, Yin SS, Chen H, Zhou C, et al
    Chemotaxis of Vdelta2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 2. pii: annrheumdis-2016-211069.
    PubMed     Abstract available


  273. BREBAN M, Tap J, Leboime A, Said-Nahal R, et al
    Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.
    Ann Rheum Dis. 2017;76:1614-1622.
    PubMed     Abstract available


    August 2017
  274. TAKEUCHI T, Thorne C, Karpouzas G, Sheng S, et al
    Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study.
    Ann Rheum Dis. 2017 Aug 30. pii: annrheumdis-2017-211328.
    PubMed     Abstract available


  275. FILER A, Ward LSC, Kemble S, Davies CS, et al
    Identification of a transitional fibroblast function in very early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 28. pii: annrheumdis-2017-211286.
    PubMed     Abstract available


  276. OIWA H
    Concerns on glucocorticoid use for Japanese patients with established rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-212206.
    PubMed    


  277. ORYOJI K, Yoshida K, Kashiwado Y, Tanaka K, et al
    Shared epitope positivity is related to efficacy of abatacept in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-211430.
    PubMed    


  278. OLSEN CM, Green AC
    Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: an updated meta-analysis.
    Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-212205.
    PubMed    


  279. MANTEL A, Holmqvist M, Jernberg T, Wallberg-Jonsson S, et al
    Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 20. pii: annrheumdis-2017-211608.
    PubMed     Abstract available


  280. MERCER LK, Regierer AC, Mariette X, Dixon WG, et al
    Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.
    Ann Rheum Dis. 2017 Aug 19. pii: annrheumdis-2017-211623.
    PubMed     Abstract available


  281. ORELLANA C, Saevarsdottir S, Klareskog L, Karlson EW, et al
    Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
    Ann Rheum Dis. 2017 Aug 17. pii: annrheumdis-2017-211620.
    PubMed     Abstract available


  282. JONSSON MK, Sundlisaeter NP, Nordal HH, Hammer HB, et al
    Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 16. pii: annrheumdis-2017-211695.
    PubMed     Abstract available


  283. SCALLY SW, Law SC, Ting YT, Heemst JV, et al
    Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 11. pii: annrheumdis-2017-211300.
    PubMed     Abstract available


  284. BRINKMANN GH, Norli ES, Boyesen P, Heijde DVH, et al
    Role of erosions typical of rheumatoid arthritis in the 2010 ACR/EULAR rheumatoid arthritis classification criteria: results from a very early arthritis cohort.
    Ann Rheum Dis. 2017 Aug 10. pii: annrheumdis-2017-211350.
    PubMed     Abstract available


  285. KEYSTONE EC, Taylor PC, Tanaka Y, Gaich C, et al
    Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
    Ann Rheum Dis. 2017 Aug 10. pii: annrheumdis-2017-211259.
    PubMed     Abstract available


  286. EMERY P, Vencovsky J, Sylwestrzak A, Leszczynski P, et al
    Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4.
    Ann Rheum Dis. 2017 Aug 9. pii: annrheumdis-2017-211591.
    PubMed     Abstract available


  287. TAK PP, Doorenspleet ME, de Hair MJH, Klarenbeek PL, et al
    Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 8. pii: annrheumdis-2017-211351.
    PubMed     Abstract available


  288. DE JONG AJ, Klein-Wieringa IR, Kwekkeboom JC, Toes REM, et al
    Inflammatory features of infrapatellar fat pad in rheumatoid arthritis versus osteoarthritis reveal mostly qualitative differences.
    Ann Rheum Dis. 2017 Aug 5. pii: annrheumdis-2017-211673.
    PubMed    


  289. CAPORALI R, Smolen JS
    Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis management.
    Ann Rheum Dis. 2017 Aug 2. pii: annrheumdis-2017-211458.
    PubMed     Abstract available


  290. BAKER KF, Isaacs JD
    Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
    Ann Rheum Dis. 2017 Aug 1. pii: annrheumdis-2017-211555.
    PubMed     Abstract available


  291. TASAKI S, Suzuki K, Nishikawa A, Kassai Y, et al
    Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:1458-1466.
    PubMed     Abstract available


  292. LISNEY AR, Szelinski F, Reiter K, Burmester GR, et al
    High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
    Ann Rheum Dis. 2017;76:1476-1480.
    PubMed     Abstract available


  293. GLINTBORG B, Sorensen IJ, Loft AG, Lindegaard H, et al
    A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
    Ann Rheum Dis. 2017;76:1426-1431.
    PubMed     Abstract available


  294. DEKKERS JS, Verheul MK, Stoop JN, Liu B, et al
    Breach of autoreactive B cell tolerance by post-translationally modified proteins.
    Ann Rheum Dis. 2017;76:1449-1457.
    PubMed     Abstract available


  295. SCHIEIR O, Tosevski C, Glazier RH, Hogg-Johnson S, et al
    Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.
    Ann Rheum Dis. 2017;76:1396-1404.
    PubMed     Abstract available


  296. MORADI-LAKEH M, Forouzanfar MH, Vollset SE, El Bcheraoui C, et al
    Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013.
    Ann Rheum Dis. 2017;76:1365-1373.
    PubMed     Abstract available


    July 2017
  297. MICHELSEN B, Kristianslund EK, Sexton J, Hammer HB, et al
    Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.
    Ann Rheum Dis. 2017 Jul 21. pii: annrheumdis-2017-211284.
    PubMed     Abstract available


  298. HOLMQVIST M, Ljung L, Askling J
    Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks.
    Ann Rheum Dis. 2017 Jul 14. pii: annrheumdis-2016-211066.
    PubMed     Abstract available


  299. VAN SCHIE KA, Ooijevaar-De Heer P, Kruithof S, Plasencia C, et al
    Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies.
    Ann Rheum Dis. 2017;76:1285-1288.
    PubMed     Abstract available


  300. BOUTET MA, Najm A, Bart G, Brion R, et al
    IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro.
    Ann Rheum Dis. 2017;76:1304-1312.
    PubMed     Abstract available


  301. VAN ZANTEN A, Arends S, Roozendaal C, Limburg PC, et al
    Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands.
    Ann Rheum Dis. 2017;76:1184-1190.
    PubMed     Abstract available


  302. FISHER BA, Jonsson R, Daniels T, Bombardieri M, et al
    Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:1161-1168.
    PubMed     Abstract available


    June 2017
  303. CHEN YM, Huang WN, Wu YD, Lin CT, et al
    Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib: a real-world study.
    Ann Rheum Dis. 2017 Jun 29. pii: annrheumdis-2017-211322.
    PubMed    


  304. RUBBERT-ROTH A, Jacobs JWG, Bijlsma JWJ, Welsing PMJ, et al
    A disconnect between disease activity and functional ability already in patients with early rheumatoid arthritis, depending on large joint involvement.
    Ann Rheum Dis. 2017 Jun 23. pii: annrheumdis-2017-211485.
    PubMed    


  305. SMOLEN JS, Cohen SB, Tony HP, Scheinberg M, et al
    A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis.
    Ann Rheum Dis. 2017 Jun 21. pii: annrheumdis-2017-211281.
    PubMed     Abstract available


  306. HYLDGAARD C, Hilberg O, Pedersen AB, Ulrichsen SP, et al
    A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.
    Ann Rheum Dis. 2017 Jun 13. pii: annrheumdis-2017-211138.
    PubMed     Abstract available


  307. GLINATSI D, Baker JF, Hetland ML, Horslev-Petersen K, et al
    Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled tr
    Ann Rheum Dis. 2017 Jun 13. pii: annrheumdis-2017-211315.
    PubMed     Abstract available


  308. GEORGE MD, Ostergaard M, Conaghan PG, Emery P, et al
    Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2017-211569.
    PubMed     Abstract available


  309. ARTS EE, Fransen J, Den Broeder AA, van Riel PLCM, et al
    Low disease activity (DAS28</=3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.
    Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2016-210997.
    PubMed     Abstract available


  310. BOUMAN CA, Herwaarden NV, van den Hoogen FH, Fransen J, et al
    Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trial.
    Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2017-211169.
    PubMed     Abstract available


  311. BELKHIR R, Burel SL, Dunogeant L, Marabelle A, et al
    Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.
    Ann Rheum Dis. 2017 Jun 9. pii: annrheumdis-2017-211216.
    PubMed     Abstract available


  312. HUMPHREYS JH, Costello R, Verstappen SM, Dixon WG, et al
    Response to: Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis by Kremer and Weinblatt.
    Ann Rheum Dis. 2017 Jun 8. pii: annrheumdis-2017-211670.
    PubMed    


  313. KREMER JM, Weinblatt ME
    Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Ann Rheum Dis. 2017 Jun 8. pii: annrheumdis-2017-211632.
    PubMed    


  314. THOMSEN T, Aadahl M, Beyer N, Hetland ML, et al
    The efficacy of motivational counselling and SMS reminders on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial.
    Ann Rheum Dis. 2017 Jun 5. pii: annrheumdis-2016-210953.
    PubMed     Abstract available


  315. COHEN S, Genovese MC, Choy E, Perez-Ruiz F, et al
    Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study.
    Ann Rheum Dis. 2017 Jun 5. pii: annrheumdis-2016-210459.
    PubMed     Abstract available


  316. BRITO-ZERON P, Acar-Denizli N, Zeher M, Rasmussen A, et al
    Influence of geolocation and ethnicity on the phenotypic expression of primary Sjogren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjogren Project Consortium.
    Ann Rheum Dis. 2017;76:1042-1050.
    PubMed     Abstract available


    May 2017
  317. MEISSNER Y, Richter A, Manger B, Tony HP, et al
    Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort.
    Ann Rheum Dis. 2017 May 8. pii: annrheumdis-2017-211209.
    PubMed     Abstract available


  318. SMOLEN JS, Landewe RBM, van der Heijde D
    Response to: '2016 update of the EULAR recommendations for the management of rheumatoid arthritis: no utopia for patients in low/middle-income countries?' by Misra et al.
    Ann Rheum Dis. 2017 May 6. pii: annrheumdis-2017-211455.
    PubMed    


  319. BUTTGEREIT F, Bijlsma JW
    Glucocorticoids in rheumatoid arthritis: the picture is shaping up.
    Ann Rheum Dis. 2017 May 4. pii: annrheumdis-2017-211187.
    PubMed    


  320. PARK JK, Lee MA, Lee EY, Song YW, et al
    Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Ann Rheum Dis. 2017 May 3. pii: annrheumdis-2017-211128.
    PubMed     Abstract available


  321. OGDIE A, Harter L, Shin D, Baker J, et al
    The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study.
    Ann Rheum Dis. 2017;76:882-885.
    PubMed     Abstract available


    April 2017
  322. SAFY M, Jacobs J, IJff ND, Bijlsma J, et al
    Long-term outcome is better when a methotrexate-based treatment strategy is combined with 10 mg prednisone daily: follow-up after the second Computer-Assisted Management in Early Rheumatoid Arthritis trial.
    Ann Rheum Dis. 2017 Apr 27. pii: annrheumdis-2016-210647.
    PubMed     Abstract available


  323. PIRILA L, Sokka T, Kauppi MJ, Rantalaiho VM, et al
    Alternative interpretation of data for recommendations on how to manage rheumatoid arthritis.
    Ann Rheum Dis. 2017 Apr 27. pii: annrheumdis-2017-211505.
    PubMed    


  324. CRUZ GI, Shao X, Quach H, Ho KA, et al
    Increased risk of rheumatoid arthritis among mothers with children who carry DRB1 risk-associated alleles.
    Ann Rheum Dis. 2017 Apr 8. doi: 10.1136/annrheumdis-2016-210662.
    PubMed     Abstract available


  325. BURMESTER GR, Rigby WF, van Vollenhoven RF, Kay J, et al
    Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial.
    Ann Rheum Dis. 2017 Apr 7. pii: annrheumdis-2016-210561.
    PubMed     Abstract available


    March 2017
  326. CHATZIDIONYSIOU K, Emamikia S, Nam J, Ramiro S, et al
    Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Ann Rheum Dis. 2017 Mar 29. pii: annrheumdis-2016-210711.
    PubMed     Abstract available


  327. MISRA DP, Agarwal V, Sharma A, Wakhlu A, et al
    2016 update of the EULAR recommendations for the management of rheumatoid arthritis: a utopia beyond patients in low/middle income countries?
    Ann Rheum Dis. 2017 Mar 27. pii: annrheumdis-2017-211446.
    PubMed    


  328. HUMPHREYS JH, Warner A, Costello R, Lunt M, et al
    Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Ann Rheum Dis. 2017 Mar 23. pii: annrheumdis-2016-210629.
    PubMed     Abstract available


  329. MANIVEL VA, Mullazehi M, Padyukov L, Westerlind H, et al
    Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Ann Rheum Dis. 2017 Mar 23. pii: annrheumdis-2016-210873.
    PubMed     Abstract available


  330. CHARRAS A, Konsta OD, Le Dantec C, Bagacean C, et al
    Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:625-628.
    PubMed     Abstract available


  331. ROSS EA, Naylor AJ, O'Neil JD, Crowley T, et al
    Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression.
    Ann Rheum Dis. 2017;76:612-619.
    PubMed     Abstract available


  332. THORARENSEN SM, Lu N, Ogdie A, Gelfand JM, et al
    Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis.
    Ann Rheum Dis. 2017;76:521-525.
    PubMed     Abstract available


    February 2017
  333. MAEHARA T, Mattoo H, Ohta M, Mahajan VS, et al
    Lesional CD4+ IFN-gamma+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis.
    Ann Rheum Dis. 2017;76:377-385.
    PubMed     Abstract available


  334. ROSSETTI M, Spreafico R, Consolaro A, Leong JY, et al
    TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis.
    Ann Rheum Dis. 2017;76:435-441.
    PubMed     Abstract available


  335. NORDBERG LB, Lillegraven S, Lie E, Aga AB, et al
    Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naive patients classified according to the 2010 ACR/EULAR criteria.
    Ann Rheum Dis. 2017;76:341-345.
    PubMed     Abstract available


    January 2017
  336. ALAWI KM, Russell FA, Aubdool AA, Srivastava S, et al
    Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation.
    Ann Rheum Dis. 2017;76:252-260.
    PubMed     Abstract available


  337. BELL GM, Anderson AE, Diboll J, Reece R, et al
    Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis.
    Ann Rheum Dis. 2017;76:227-234.
    PubMed     Abstract available


  338. DOUGADOS M, van der Heijde D, Chen YC, Greenwald M, et al
    Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
    Ann Rheum Dis. 2017;76:88-95.
    PubMed     Abstract available


  339. SHIBOSKI CH, Shiboski SC, Seror R, Criswell LA, et al
    2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.
    Ann Rheum Dis. 2017;76:9-16.
    PubMed     Abstract available


  340. CAPPELLI LC, Gutierrez AK, Baer AN, Albayda J, et al
    Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.
    Ann Rheum Dis. 2017;76:43-50.
    PubMed     Abstract available


  341. HENSVOLD AH, Frisell T, Magnusson PK, Holmdahl R, et al
    How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins.
    Ann Rheum Dis. 2017;76:119-125.
    PubMed     Abstract available


  342. CHOE JY, Prodanovic N, Niebrzydowski J, Staykov I, et al
    A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.
    Ann Rheum Dis. 2017;76:58-64.
    PubMed     Abstract available


  343. EMERY P, Vencovsky J, Sylwestrzak A, Leszczynski P, et al
    A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy.
    Ann Rheum Dis. 2017;76:51-57.
    PubMed     Abstract available


    October 2016
  344. HUNT L, Hensor EM, Nam J, Burska AN, et al
    T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals.
    Ann Rheum Dis. 2016;75:1884-9.
    PubMed     Abstract available


  345. VAN HEEMST J, Hensvold AH, Jiang X, van Steenbergen H, et al
    Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.
    Ann Rheum Dis. 2016;75:1891-8.
    PubMed     Abstract available


  346. CORSIERO E, Bombardieri M, Carlotti E, Pratesi F, et al
    Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs.
    Ann Rheum Dis. 2016;75:1866-75.
    PubMed     Abstract available


  347. VAN STEENBERGEN HW, Mangnus L, Reijnierse M, Huizinga TW, et al
    Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis.
    Ann Rheum Dis. 2016;75:1824-30.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: